Xác nhận chức năng GPCR: Làm thế nào để chứng minh protein tinh khiết của bạn vẫn "sống"

After investing significant effort into GPCR Membrane Protein Expression And Purification, researchers face a critical question: Is the purified receptor still functional? For G protein-coupled receptors (GPCRs)—notoriously fragile and conformationally complex—simply obtaining a protein band on a gel is not enough. Functional validation is the essential proof that your purified GPCR retains its biological activity. This article examines how scientists check for "life" in a purified membrane protein to confirm its readiness for structural analysis or drug development.

Importance of Functional Validation for GPCRs

GPCRs are multi-state-signaling proteins. They can exist in various conformational states (inactive, active, and different intermediate states). Detergents, during GPCR Membrane Protein Expression And Purification, can remove native lipids, which can destabilize the receptor, or actively keep the receptor in an inactive conformation. The two-part functional validation essentially addresses the following:

• Is the isolated GPCR capable of ligand binding?

• Is the isolated GPCR capable of G-protein coupling and/or can it undergo any conformational change?

In the absence of these validations, a GPCR preparation, no matter how high-yield, will be inadequate for cryo-EM, crystallization, or any mechanistic pharmacology.

Historical and Contemporary Examples

There are two significant examples where the validation of purified GPCRs received a lot of attention:

1996 – Kobilka et al. (Gether et al.) – showed, by a novel use of fluorescent agonists, that the purified GPCR, β2-adrenergic receptor, can retain ligand binding and G-protein activation after being incorporated in liposomes. This was the first example that set the benchmark for functional validation of GPCRs after purification.

2021 – Kato, H.E., et al. (Nature) – showed several high-resolution cryo-EM images of the μ-opioid receptor in different active states, and that the μ-opioid receptor was purified and functionally validated by the conformational nanobody, GTPγS, and ELISA assays. Their study showed that functional validation of the receptor is critical and correlates with high-resolution cryo-EM studies.

These studies reinforce that rigorous functional testing is inseparable from successful GPCR Membrane Protein Expression And Purification.

Core Methods to Prove Your GPCR Is "Alive"

Below are the most widely used functional validation techniques, each addressing a different aspect of GPCR activity.

1. Radioligand Binding Assays (Both Classic & Quantitative)

• Principle: When purified GPCRs are incubated with a radioactive ligand (agonist/antagonist), what happens?

• What it proves: Binding tells us if the pocket is folded and if the pocket is accessible.

• Typical readouts: Kd, Bmax

• Limitations: Without state-specific ligands, we cannot know anything about the inactive/active state of the GPCR.

2. GTPγS Binding (Direct G Protein Activation Test)

• Principle: The GPCR is purified and incorporated in lipid vesicles/nanodiscs along with heterotrimeric G Proteins. The non-hydrolyzable nucleotide [35S]GTPγS is then added. An active GPCR will bind GTPγS and G Proteins.

• What it proves: Active G Proteins means that GPCRs bind the first signaling partner of the pathway and thus the GPCR activates the first step of the signaling cascade.

• Best for: This is good for exploring mechanisms that are beyond ligand binding.

3. NanoBRET & FRET-Based Conformational Sensors

• Principle: One of the GPCRs is tagged with a donor fluorophore, and a small, membrane-permeable ligand or biosensor (e.g. nanobody) acting as acceptor is also available. GPCR conformational changes will be accompanied by a proximity change of the donor/acceptor pair and a resultant BRET/FRET signal after agonist addition.

• What it proves: This assay is capable of detecting conformational change of the GPCR between inactive and active states in real time.

• Advantage: The BRET/FRET assay is performed in detergent and is high-throughput.

4. Reconstitution into Liposomes or Nanodiscs

• What is the principle? GPCRs are integrated into Nanodiscs or liposomes that contain liposomal bilayer membranes. The bilayer membranes that contain liposomal G proteins are in a cell-free situation.

• What is it showing? A lipid environment is necessary for function GPCRs.

5. Conformation-Specific Antibody or Nanobody Binding

• Principle: For GPCRs use either conformation-specific nanobodies or antibodies, for example, the use of Nb80 for β2AR in the active or inactive state of GPCRs.

• What does it show? The receptor is captured in a particular active or inactive functional state.

• Why is this important? This is important when performing cryo-EM on a single conformation.

Function Validation in a GPCR Process

A GPCR Membrane Protein Expression And Purification service should offer functional validation as a standard for their quality control, comprising the following:

Step 1 - Scoping & design: functional endpoint (e.g. binding, G protein activation, conformation, etc.) is established.

Step 2 - Expression and purification. GPCRs are co-expressed with stabilizing components.

Step 3 - Quality assessment. SDS-PAGE, SEC, Mass Spectrometry.

Step 4 - Functional assessment. Radiolabeled and GTPγS binding assays, FRET, etc.

Step 5 – Downstream use: Cryo-EM preparation or drug screening if functional criteria are satisfied.

What Longlight Technology Brings for Functional GPCR Validation

Longlight Technology offers a full range of membrane protein R&D services with integrated functional validation. Their Development of Membrane Protein platform focuses on challenging GPCR targets.

Some benefits are:

• Full scope: Expertise in GPCR Membrane Protein Expression And Purification and functional studies.

• SBDD Applicable: The samples that have passed the validation of their conformation are prepared for cryo-EM/X-Ray.

• Entire: Scoping, expression, purification, cryo-EM, and all data included.

• Structural biology pertinent: Functional validation propels precise 2D grid and 3D data pertaining to reconstruction.

What they do:

• Scoping and design: Determine target and structure stabilization.

• Expression and purification: Quality criteria are met by target.

• Sample & data for Cryo-EM: Grid and Vitrification.

• Reconstruction & delivery: Structural model for structure-based drug design.

*Note: All services are for research use only*

Practical Takeaways for Researchers

As you set criteria for your GPCR Membrane Protein Expression And Purification project, consider the following:

• Don't skip functional validation. Lack of functional activity does not guarantee that the receptor is inactive.

• Design your assay with the end goal in mind, i.e., ligand binding will be necessary for epitope mapping. GTPγS will be necessary for cellular signaling, and conformational probes for cryo-EM.

• Lipid reconstitution may be vital. GPCRs have varying need for native like lipids for functional activity.

• Positive and negative controls are a must. Functional validation of the assay can be accomplished with a known agonist and inverse agonist.

Conclusion.

Demonstrating that a purified GPCR is functional is not an optional extra. It is the one and only way to bridge the GPCR Membrane Protein Expression And Purification with valuable biological or structural data. When combined with novel techniques, (nanoBRET, conformation specific nanobodies) classic methods (radioligand binding, GTPγS) can be utilized to confidently validate samples. Integrated with a functional GPCR, Longlight Technology's incorporated platform is designed to address this need and support the critical step of validation for downstream processes. Remember, a functional GPCR is the basis for reliable drug discovery and structural biology.

Get Free Quote | Contact Longlight Technology for customized GPCR expression, purification and functional validation services.

FAQs.

Q1. Why is functional validation necessary after the purification of GPCR?

A: Functional validation is crucial in determining if the receptor is capable of G protein coupling and ligand binding, and not just verifying if it has the structural fold.

Q2. Is it enough to only perform SDS-PAGE to check if my GPCR is functional?

A: No, SDS-PAGE is not a functional validation method. It only checks the GPCR purity and its molecular weight.

Q3. What is the quickest method to functionally assay the purified GPCRs?

A: A very fast and quantitative method is a radioligand binding assay, and it is widely used to test receptor folding.

Q4. Do purified GPCRs always have to be reconstituted into lipids?

A: No. There are many GPCRs that require at least nanodiscs or liposomes to be fully functionally active, but some DGMs, or detergent-based systems, keep GPCRs functional.

Q5. What is the method that shows G Protein activation in a direct way?

A: The ligand binding to the receptor in a reconstituted system and G protein activation is shown in the GTPγS binding assay.